SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
136 Reading the press release I'm not getting pessimistic. Instead everything lDirk Boodts-1/9/1997
135 In the US market alone the company is adding about 3,000 patients to avonex eveHarold Engstrom-1/9/1997
134 Correct you are.Dave L-1/9/1997
133 Harold, its clear the market was not impressed with Bgen's preliminary earnVector1-1/8/1997
132 You're right, I forgot about the CBM R&D payment. But, the purchase ofHarold Engstrom-1/8/1997
131 David, I think you are correct. The WSJ news item confirms your theory. In the Cynic 2005-1/8/1997
130 Remember the Creative BioMolecules deal called for an immediate payment of $10 Dave L-1/8/1997
129 Mohan, I agree that the earnings reported unofficially by Mr. Vincent seem low.Harold Engstrom-1/7/1997
128 Harold, I just looked the Biogen PR release and got concerned at the projected Cynic 2005-1/7/1997
127 Rick, what is going on with VLA4 and Gelsolin? Thanks, Harold EngstromHarold Engstrom-1/7/1997
126 Thanks!!! I sleep very well / owning Biogen. JimJim Odell-1/2/1997
125 Jim, check Rick's posts on this thread. He gave a detailed reply to this quCynic 2005-1/2/1997
124 To all; Any info as to when Biogen will receive overseas licence to sell AvonexJim Odell-1/2/1997
123 Rick, how committed is Biogen to VLA4 and Gelsolin? These drugs would seem to Harold Engstrom-1/2/1997
122 I read your comments carefully, believe me. Only SI could tell you by how many Boyce Burge-1/1/1997
121 I agree. I only wanted to point out how I think these games are being played.bob smith-12/31/1996
120 This is not a sucker stock to own. And people generally buy in heavier volumesHarold Engstrom-12/31/1996
119 Yeah, I tought i'll buy some this am. But wen and I looked at a three daybob smith-12/31/1996
118 To All: Big recommendation to Buy Biogen on CNBC. This morning Maria B. said Stanley Cowen-12/31/1996
117 To Rick Lundberg: Comparison of your 9/23/96 post with 12/23 PRNewswire story Stanley Cowen-12/30/1996
116 For a drug in this category, the top down sales driving factors are: 1) efficThean-12/30/1996
115 It looks that the market don't trust the new product. The chart LOOKED so nDirk Boodts-12/29/1996
114 Teva's Copaxone got FDA approval to reduce severity of attacks according toStanley Cowen-12/26/1996
113 That was probably Teva's Copaxone that got approval. There was an extremelHarold Engstrom-12/26/1996
112 Harold, I seen story, came across Reuters at 4.11 pm E.T. basically it said thaMichael H. Dragon-12/24/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News